業績

小林　起穂

【掲載論文】
1． 谷本起穂：繊維芽細胞増殖因子受容体(FGFR)2のApert型変異(S252W)による骨芽細胞の分化および石灰化の亢進．四国歯誌16(1), 237-261 (2003)
2． Tanimoto Y, Yokozeki M, Kenji H, Matsumoto K, Nakanishi H, Matsumoto T, Marie PJ and Moriyama K: A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation In Apert syndrome. J Biol Chem 279(44), 45926-45934 (2004)
3． 谷本起穂：繊維芽細胞増殖因子受容体の変異と骨系統疾患．四国歯誌18(2)，187-193（2006）　
4． 松本和也、中西秀樹、高瀬真記、古泉佳男、谷本起穂、森山啓司：トリチャーコリンズ症候群に対する下顎骨延長の中期成績. 形成外科49(3), 311-317 (2006)　
5． Kinouchi N, Ohsawa Y, Ishimaru N, Ohuchi H, Sunada Y, Hayashi Y, Tanimoto Y, Moriyama K, Noji S: Atelocollagen-mediated local and systemic applications of myostatin-targeting siRNA increase skeletal muscle mass. Gene Ther. 15(15), 1126-30 (2008)
6． Miraoui H, Oudina K, Petite H, Tanimoto Y, Moriyama K, Marie PJ: Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. J Biol Chem. 284(8), 4897-904 (2008 )
7． Rice DP, Connor EC, Veltmaat JM, Lana-Elola E, Veistinen L, Tanimoto Y, Bellusci S, Rice R.: Gli3Xt-J/Xt-J mice exhibit lambdoid suture craniosynostosis which results from altered osteoprogenitor proliferation and differentiation. Hum Mol Genet.19(17):3457-67(2010)

【著 書】
1．Yokozeki M, Tanimoto Y, Matsumoto K, Nakanishi H, Hiura K and Moriyama K: Craniofacial and dental manifestations in an Apert syndrome patient: Participation of osteoblastic cells in phenotypic expression of craniosynostosis syndrome. Orthodontics in the 21st Century, Osaka, Osaka University Press, 151-155 (2002)

【総 説】
1．森山啓司，谷本起穂 : 繊維芽細胞増殖因子受容体2(FGFR2) 生体の科学 56, 416-417 (2005)


【症例報告】
1．Matsumoto K, Nakanishi H, Koizumi Y, Seike T, Tanimoto Y, Yokozeki M, Moriyama K, Minami M, Urano Y and Hirabayashi S: Correction of a deformed thumb by distraction of the phalanx. Scand J Plast Reconstr Surg Hand Surg 36, 368-372 (2002)